-
srdr.ahrq.gov/projects/1520/studies/186810
January 01, 2019 - )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/189213
January 01, 2013 - Population: All Participants
Time Point
Measure
CPAP
Baseline N/A
N Analyzed … SD
24.9
SE
17.8 (11.4) months
N Analyzed … Population: All Participants
Time Point
Measure
CPAP
17.8 (11.4) months
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186741
January 01, 2010 - Elective surgery
Enter a numeric value or title (required) years
N Analyzed
3468 … Elective surgery
Enter a numeric value or title (required) years
N Analyzed
3468 … Elective surgery
Enter a numeric value or title (required) years
N Analyzed
3468 … Elective surgery
30 days
N Analyzed
3468
3502
P-Value
0.0004 … Elective surgery
N/A years
N Analyzed
3468
3502
P-Value
0.0039
-
srdr.ahrq.gov/projects/1565/studies/189572
January 01, 2013 - No CPAP
Baseline N/A
N Analyzed
56
35 … 41.2
Note
36.5+/-3.7 months
N Analyzed … No CPAP
Baseline N/A
N Analyzed
56
35 … 65.0
Note
36.5+/-3.7 months
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/189189
January 01, 2015 - No CPAP
Baseline N/A
N Analyzed
33
93 … 0.85
0.52
SE
10 years
N Analyzed … No CPAP
Baseline N/A
N Analyzed
33
93 … 0.25
Note
SE
10 years
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/198894
January 01, 2004 - No CPAP
Before N/A
N Analyzed
82
89 … 1.04
0.96
SE
>6 months
N Analyzed … No CPAP
Before N/A
N Analyzed
82
89 … 0.81
0.74
SE
>6 months
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186750
January 01, 2014 - Pharm: 5-ASA (4.8 g/d)
104 weeks
N Analyzed
147
143
143 … Measure
Placebo
Pharm: 5-ASA (1.2 g/d)
Pharm: 5-ASA (2.4 g/d)
Pharm: 5-ASA (4.8 g/d)
104 weeks
N Analyzed … Measure
Placebo
Pharm: 5-ASA (1.2 g/d)
Pharm: 5-ASA (2.4 g/d)
Pharm: 5-ASA (4.8 g/d)
104 weeks
N Analyzed … Measure
Placebo
Pharm: 5-ASA (1.2 g/d)
Pharm: 5-ASA (2.4 g/d)
Pharm: 5-ASA (4.8 g/d)
104 weeks
N Analyzed … Measure
Placebo
Pharm: 5-ASA (1.2 g/d)
Pharm: 5-ASA (2.4 g/d)
Pharm: 5-ASA (4.8 g/d)
104 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/198064
January 01, 2021 - CPAP
2.5 years
N Analyzed
260
318 … CPAP
2.5 years
N Analyzed
260
318 … No CPAP
2.5 years
N Analyzed
260
318
-
srdr.ahrq.gov/projects/1565/studies/188512
January 01, 2019 - Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … No CPAP
Enter a numeric value or title (required) years
N Analyzed
1030
-
srdr.ahrq.gov/projects/1520/studies/193255
January 01, 2019 - Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/192909
January 01, 2019 - Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186844
January 01, 2017 - Pharm: rifaximin
15 months
N Analyzed
72
52
Adj. … Population: All Participants
Time Point
Measure
Pharm: rifaximin
Pharm: 5-ASA
15 months
N Analyzed … Population: All Participants
Time Point
Measure
Pharm: rifaximin
Pharm: 5-ASA
15 months
N Analyzed … Population: All Participants
Time Point
Measure
Pharm: rifaximin
Pharm: 5-ASA
24 months
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/197240
January 01, 2020 - )
Population: All Participants
Time Point
Measure
Elective surgery
1 years
N Analyzed … 6811
Counts
129
Percentage
1.9
3 years
N Analyzed
6811 … Counts
272
Percentage
4.0
5 years
N Analyzed
6811
Counts
-
srdr.ahrq.gov/projects/1520/studies/186228
January 01, 2012 - Setting: Outpatient management
9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months
N Analyzed … Setting: Outpatient management
9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months
N Analyzed … Setting: Outpatient management
9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months
N Analyzed … Setting: Outpatient management
9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188743
January 01, 2016 - No CPAP
53 (IQR 41-77) months
N Analyzed
Adj. … No CPAP
53 (IQR 41-77) months
N Analyzed
Adj. … No CPAP
50 (IQR 23-77) months
N Analyzed
Adj. 95% CI low
-
srdr.ahrq.gov/projects/1520/studies/186845
January 01, 2014 - Time Point
Measure
Pharm: 5-ASA (4.8 g/d)
Enter a numeric value or title (required) years
N Analyzed … Time Point
Measure
Pharm: 5-ASA (4.8 g/d)
Enter a numeric value or title (required) years
N Analyzed … Time Point
Measure
Pharm: 5-ASA (4.8 g/d)
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186848
January 01, 2018 - Time Point
Measure
Colonoscopy
No Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Time Point
Measure
Colonoscopy
No Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186799
January 01, 2019 - Antibiotics: Cephalosporin + Metronidazole
Enter a numeric value or title (required) years
N Analyzed … Antibiotics: Cephalosporin + Metronidazole
Enter a numeric value or title (required) years
N Analyzed … Antibiotics: Cephalosporin + Metronidazole
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186762
January 01, 2014 - Pharm: 5-ASA
104 weeks
N Analyzed
142
148
147
149 … Participants
Time Point
Measure
Placebo
Pharm: 5-ASA
Pharm: 5-ASA
Pharm: 5-ASA
104 weeks
N Analyzed … Participants
Time Point
Measure
Placebo
Pharm: 5-ASA
Pharm: 5-ASA
Pharm: 5-ASA
104 weeks
N Analyzed … Participants
Time Point
Measure
Placebo
Pharm: 5-ASA
Pharm: 5-ASA
Pharm: 5-ASA
104 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1542/studies/189228
January 01, 2015 - Time Point
Measure
Single-pulse transcranial magnetic stimulation
Unclear N/A
N Analyzed … Time Point
Measure
Single-pulse transcranial magnetic stimulation
Unclear N/A
N Analyzed … Time Point
Measure
Single-pulse transcranial magnetic stimulation
Unclear N/A
N Analyzed